Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline    GSK   GB0009252882

GLAXOSMITHKLINE

(GSK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Most relevant news about GLAXOSMITHKLINE
04:15aGSK to sell two vaccines in $1.1 billion deal to focus on newer treatments
RE
04:11aGLAXOSMITHKLINE : GSK agrees to divest rabies and tick-borne encephalitis vaccin..
AQ
03:58aGlaxoSmithKline to Sell Two Former Novartis Vaccines for up to EUR955 Million
DJ
03:16aGLAXOSMITHKLINE : GSK divests two travel vaccines to Bavarian Nordic
PU
10/18Sanofi pulls Zantac from U.S. and Canada after carcinogen found
RE
10/17TEVA PHARMACEUTICAL INDUSTRIES : UK arm recalls some batches of Ranitidine - Med..
RE
10/16Factbox - How are businesses preparing for a 'no-deal Brexit'?
RE
10/15EUROPE MARKETS: European Stocks Surge To Best Level In 16 Months On Brexit Op..
DJ
10/15LONDON MARKETS: Pound Surges On Report Of Possible Draft Brexit Deal
DJ
10/12LONDON MARKETS: Brexit Hopes Sends British Pound To Highest Level Of Johnson ..
DJ
10/09UK accounting watchdog to get 80 more 'teeth'
RE
10/08GSK recalls popular heartburn drug Zantac globally after cancer scare
RE
10/08Glaxo Links Up with US Biotech to Target Solid Tumors with Cell Therapy
DJ
10/08GLAXOSMITHKLINE : Zantac - MHRA drug alert issued as GlaxoSmithKline recalls all..
AQ
10/07LONDON STOCK EXCHANGE : Trade hopes lift FTSE 100, SIG drags down mid-caps
RE
10/04Vectura, Sandoz win ruling on inhaler packaging case against GSK
RE
10/02GLAXOSMITHKLINE : GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients ..
BU
10/01ASTRAZENECA : combo lung disease therapy fails to win FDA approval
RE
09/30Health Care Up as Growth-to-Value Rotation Slows -- Health Care Roundup
DJ
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30EUROPE : Weak euro, Wall Street rally buoy European shares
RE
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30GLAXOSMITHKLINE : Phase 3 PRIMA trial of Zejula® (niraparib) is the first study ..
AQ
09/30AstraZeneca strengthens Lynparza push with prostate cancer data
RE
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30GLAXOSMITHKLINE : Phase 3 PRIMA trial of Zejula is the first study to show a PAR..
AQ
09/30GLAXOSMITHKLINE : GSK presents new data showing promising anti-tumour activity w..
AQ
09/30GLAXOSMITHKLINE : Nucala significantly reduces exacerbations in first global pro..
PU
09/30GLAXOSMITHKLINE : GSK presents new data showing promising anti-tumour activity w..
AQ
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/30GLAXOSMITHKLINE : Says Ovarian Cancer Study Validates Tesaro Acquisition
DJ
09/30GLAXOSMITHKLINE : PRIMA shows Zejula improves PFS in ovarian cancer
PU
09/30GLAXOSMITHKLINE : Data show anti-tumour activity with ICOS agonist
PU
09/30NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/29NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/28GLAXOSMITHKLINE : Says Ovarian Cancer Study Validates Tesaro Acquisition
DJ
09/28GLAXOSMITHKLINE : Says Ovarian Cancer Study Validates Tesaro Acquisition
DJ
09/24GLAXOSMITHKLINE : Real-world effectiveness evidence among GSK data presented at ..
AQ
09/19Microsoft Plans Board Changes -- Update
DJ
09/19MICROSOFT : Plans Board Changes
DJ
09/12GLAXOSMITHKLINE : FDA Approves GlaxoSmithKline's Nucala For Children Ages 6-11 W..
DJ
09/12GLAXOSMITHKLINE : Nucala is the first biologic approved in the US for six to 11-..
BU
09/12GLAXOSMITHKLINE : ViiV Healthcare - Stigma and mental health challenges remain b..
AQ
09/10LONDON STOCK EXCHANGE : JD Sports leads FTSE 100 higher, rate cut hopes support
RE
09/09UK bluechips give up gains as sterling strengthens
RE
09/05LONDON STOCK EXCHANGE : Strong sterling knocks FTSE 100 despite trade lull
RE
09/05PERRIGO : Buys Prevacid U.S. OTC Rights From GlaxoSmithKline
DJ
09/04UK Plc's discount steepens as political crisis over Brexit deepens
RE
08/29AstraZeneca lupus drug shows promise after set-back last year
RE
08/28AstraZeneca respiratory business gets boost from three-drug inhaler results
RE
08/27Expensive assets make Nestle picky on M&A - CFO
RE
08/26GLAXOSMITHKLINE : GSK announces positive headline results from the pivotal DREAM..
AQ
08/23GSK builds oncology pipeline as drug shown to help myeloma patients
RE
08/23GLAXOSMITHKLINE : GSK - positive results from pivotal DREAMM-2 study
PU
08/23GLAXOSMITHKLINE : Achieves Positive Results Blood Cancer Treatment Study
DJ
08/22GSK submits first regulatory application for daprodustat in Japan for patient..
AQ
08/22GSK's long acting HIV injection gets boost from study
RE
08/22GLAXOSMITHKLINE : ViiV Healthcare Reports Positive HIV Trial Results
DJ
08/22GLAXOSMITHKLINE : ViiV results positive for every 2 month injection
PU
08/21LONDON STOCK EXCHANGE : Oil majors, exporters boost FTSE 100; Fed minutes eyed
RE
08/21GSK SUBMITS REGULATORY FILE IN JAPAN : Daprodustat
PU
08/19Who is next in big pharma's merger spree?
RE
08/14Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
RE
08/08Merck KGaA's profit bolstered by lab supplies, drug milestone payments
RE
08/08GLAXOSMITHKLINE : Ex-dividend day for interim dividend
FA
08/06GSK ends development of Ebola vaccine, hands work to U.S. institute
RE
08/05IBM and other companies launch new blockchain network for supply management
RE
08/01GLAXOSMITHKLINE : Asthma Treatment Gets Green Light From EC for Self Administeri..
DJ
08/01GLAXOSMITHKLINE : EU approval for Nucala self-administration
PU
07/31ViiV Healthcare - Five years on, 3.9 million people in the developing world h..
AQ
07/31GLAXOSMITHKLINE : ViiV Healthcare group - Five years on, 3.9 million people in t..
AQ
07/30GLAXOSMITHKLINE : ViiV Healthcare submits regulatory application to European Med..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on GLAXOSMITHKLINE